These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
451 related items for PubMed ID: 5796027
1. [Present state of heparin therapy]. Blatrix C, Soulier JP, Vacheron A, Cornu P. Presse Med (1893); 1969 Mar 26; 77(15):553-6. PubMed ID: 5796027 [No Abstract] [Full Text] [Related]
2. Blood coagulation studies and extracorporeal circulation in man. Thurnherr N. Thromb Diath Haemorrh; 1967 Dec 31; 18(3-4):634-46. PubMed ID: 5590250 [No Abstract] [Full Text] [Related]
3. Heparin rebound. Studies in patients and volunteers. Ellison N, Beatty CP, Blake DR, Wurzel HA, MacVaugh H. J Thorac Cardiovasc Surg; 1974 May 31; 67(5):723-9. PubMed ID: 4823307 [No Abstract] [Full Text] [Related]
5. Control of heparin therapy. Wessler S, Gitel S. Prog Hemost Thromb; 1976 Sep 31; 3():311-29. PubMed ID: 781735 [No Abstract] [Full Text] [Related]
6. Development of heparin fractions: some overlooked considerations. Fareed J. Semin Thromb Hemost; 1985 Apr 31; 11(2):227-36. PubMed ID: 3898374 [No Abstract] [Full Text] [Related]
7. Implications of anticoagulant therapy. Ellison N, Jobes DR, Schwartz AJ. Int Anesthesiol Clin; 1982 Apr 31; 20(4):121-35. PubMed ID: 6757142 [No Abstract] [Full Text] [Related]
8. Adverse reactions associated with heparin therapy for ischemic heart disease and thrombophlebitis. Mishler JM. Am J Hosp Pharm; 1973 Dec 31; 30(12):1158-61. PubMed ID: 4763223 [No Abstract] [Full Text] [Related]
9. Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations. Rhodes GR, Dixon RH, Silver D. Surg Gynecol Obstet; 1973 Mar 31; 136(3):409-16. PubMed ID: 4688805 [No Abstract] [Full Text] [Related]
10. [Changes in the adhesiveness of thrombocytes under the effect of anticoagulants]. Merkulov MF, Lakin KM, Fel'dbaum VA, Efimov VS. Farmakol Toksikol; 1968 Mar 31; 31(6):706-9. PubMed ID: 5713582 [No Abstract] [Full Text] [Related]
11. Comparison of activated recalcification and partial thromboplastin tests as controls of heparin therapy. Ray PK, Harper TA. J Lab Clin Med; 1971 Jun 31; 77(6):901-7. PubMed ID: 5559859 [No Abstract] [Full Text] [Related]
12. Control and complications of intermittent heparin therapy. Norman CS, Provan JL. Surg Gynecol Obstet; 1977 Sep 31; 145(3):338-42. PubMed ID: 888052 [Abstract] [Full Text] [Related]
13. [Blood coagulation and fibrinolysis in venous blood after prophylactic use of antifibrinolytic agents in heart surgery with the use of xtracorporeal circulation]. Deutschinoff A, Dimitrov D. Folia Haematol Int Mag Klin Morphol Blutforsch; 1967 Sep 31; 88(2):166-73. PubMed ID: 4174654 [No Abstract] [Full Text] [Related]
14. Guidelines for heparin therapy. Genton E. Ann Intern Med; 1974 Jan 31; 80(1):77-82. PubMed ID: 4589514 [No Abstract] [Full Text] [Related]
15. [Control of coagulation in extracorporeal circulation. Importance of the routine use of activated blood coagulation time]. Evora PR, Brasil JC, Otaviano AG, Margarido EA, Ribeiro PJ, Reis CL, Silva JR, Secches AL. Arq Bras Cardiol; 1981 Aug 31; 37(2):89-93. PubMed ID: 7348180 [No Abstract] [Full Text] [Related]
16. [Heparin]. Aiach M, Fiessinger JN, Chousterman M. Rev Prat; 1977 Dec 11; 27(57):3953-74. PubMed ID: 345399 [No Abstract] [Full Text] [Related]
17. [Hemorrhagic complications caused by heparin therapy]. Fedorova ZD, Chuslov AG, Chermoshniuk GA, Levchenko LV, Khanin AZ. Vestn Khir Im I I Grek; 1989 Dec 11; 144(12):82-5. PubMed ID: 2638797 [Abstract] [Full Text] [Related]
18. [Heparinization in dialysis: new clinico-therapeutic directions]. Camici M, Evangelisti L. Clin Ter; 1993 Jan 11; 142(1):23-7. PubMed ID: 8472506 [Abstract] [Full Text] [Related]